Zzzquil Ultra 25 mg Oral Tablet
RxNorm 2548540
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2548540 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Zzzquil Ultra 25 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Doxylamine succinate 25 mg Oral Tablet [Zzzquil Ultra]
(Atom ID: 12638892)
PSN
Prescribable Name (PSN):
Zzzquil Ultra 25 mg Oral Tablet
(Atom ID: 12638893)
SY
Synonym (SY):
Zzzquil Ultra 25 mg Oral Tablet
(Atom ID: 12638894)
Patient Education
Doxylamine
Doxylamine is used in the short-term treatment of insomnia (difficulty falling asleep or staying asleep). Doxylamine is also used in combination with decongestants and other medications to relieve sneezing, runny nose, and nasal congestion caused by the common cold. Doxylamine should not be used to cause sleepiness in children. Doxylamine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.
[Learn More]
* Please review the disclaimer below.